바이오인

Beyond Bioethics:

A Proposal for Modernizing the Regulation of Human Biotechnologies

 

 

This report presents a proposal for a new approach to regulating reproductive medicine and biomedical research in the United States. It is the product of more than three years of research, and of a study group convened in Washington, D.C., dedicated to this subject. The members of the study group, numbering 42 people, were chosen to be representative of the different stakeholders in reproductive medicine and biomedical research, including the American Society for Reproductive Medicine (ASRM), the Federation of American Societies for Experimental Biology (FASEB), the American Association for the Advancement of Science (AAAS), the Council of Scientific Society Presidents (CSSP), the President’s Council on Bioethics, the Biotechnology Industry Organization (BIO), the National Osteoporosis Foundation (NOF), and the Food and Drug Administration (FDA). While they have intensively discussed various issues raised in this report, these organizations have not been asked to endorse this report or its final conclusions, which the report’s primary authors take full responsibility for....이하생략